Solomon, Nicole <br/><br/>
Rituximab is more effective than tacrolimus in steroid-dependent nephrotic syndrome.  [electronic resource] 

 -  Archives of disease in childhood. Education and practice edition  10 2019 
 - 279-280 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1743-0593 
<br/><br/><label>Standard No.: </label>10.1136/archdischild-2018-316537  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>B-Lymphocytes<br/>Child<br/>Humans<br/>Immunosuppressive Agents<br/>Nephrotic Syndrome<br/>Recurrence<br/>Rituximab<br/>Tacrolimus